KRAS and neoplasm: As a result, few prognostic factors have been identified in SIACs such as tumor location (duodenum vs. jejunum and ileum), microsatellite instability (MSI), tumor-infiltrating lymphocytes (TILs), and KRAS or BRAF mutations [9,10,11].